Eli Lilly Benelux
ActiveFrom the official registers: KBO 49 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Eli Lilly Benelux has been active since 1969 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20.4m and a net result of €11.5m. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 28% of 6,158 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
KBO- Status
- Active since 19-06-1969 Normal situation
- Legal form
- Public limited company
- Registered office
- Markiesstraat 1, 1000 Brussel
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Establishment unit
- 2.002.621.517 1000 Brussel, since 01-08-1969
- Financial year end
- 31 December
- Peppol
- Reachable
Who decides
- Frédéric ClaisManaging director
- Sandrine FerrièreDirector
- Auditor
- EY Réviseurs d'Entreprises SRL
- ELI LILLY NETHERLAND BV99.99%annual accounts 2025
- ELI LILLY AND COMPANYconsolidatesannual accounts 2025
- ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES0.01%annual accounts 2025
- Holdings
- Shares in 1 company ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES
How it is doing
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Turnover
- €294.3m
- ▲ 106%
- Profit
- €11.5m
- ▲ 88.2%
- Equity
- €20.4m
- ▲ 2.3%
- Total assets
- €79.7m
- ▲ 54.9%
- Staff
- 96.6 FTE
- ▲ 11.2%
Why 89raises riskLiquidity: current ratio 1.34lowers riskSize: turnover €294.3m, 96.6 FTE, total assets €79.7mFounded in 1969Legal form: public limited companyShow the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 32% on solvency, 20% on liquidity, 77% on profitability and 72% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Turnover rose in 2025from €142.7m to €294.3m ▲ 106% View
- Positive: Among the best 5% on net resultsector median €112,134 · 6,092 companies €11.5m View
- New directorslatest change 30-06-2026 · 1 in office 2 joined View
- Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
- Positive: 6 profitable years in a rowprofit 2025: €11.5m 6 years View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 22-07-2026
- Annual accounts 2024filed on 29-07-2025
- Annual accounts 2023filed on 19-07-2024
- Annual accounts 2022filed on 27-07-2023
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 15-09-2026
- Resignations & appointmentsact of 18-09-2025
- Resignations & appointmentsact of 01-07-2024
- Resignations & appointmentsact of 05-09-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Eli Lilly Benelux
- What is the company number of Eli Lilly Benelux?
- 0406.754.454. In Belgium the VAT number is the company number with BE in front: BE 0406.754.454.
- Where is Eli Lilly Benelux based?
- The registered office is at Markiesstraat 1, 1000 Brussel.Company details
- What does Eli Lilly Benelux do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Eli Lilly Benelux?
- Public limited company (NV).
- When was Eli Lilly Benelux founded?
- On 19-06-1969.
- Is Eli Lilly Benelux still active?
- Yes, Eli Lilly Benelux is an active enterprise in the KBO register.
- How many employees does Eli Lilly Benelux have?
- On average 96.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Eli Lilly Benelux?
- €294.3m in financial year 2025, according to the filed annual accounts.
- Is Eli Lilly Benelux profitable?
- In financial year 2025, Eli Lilly Benelux made a profit of €11.5m.
- Where can I find the annual accounts of Eli Lilly Benelux?
- Eli Lilly Benelux filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of Eli Lilly Benelux due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Eli Lilly Benelux
Comparable companies
- Opella Healthcare Belgium NV/SAMachelen (Brab.)
- MERCKHoeilaart
- Mirion Technologies (Canberra BNLS)Asse
- COVETRUSBeringen
- De Soutter Medical LtdBuckinghamshire
Go further with this company
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.